文献速递显微修复重建创面修复

下肢游离皮瓣重建中肝素诱导性血小板减少症发生率与总体手术人群相关

Incidence of heparin-induced thrombocytopenia in lower-extremity free flap reconstruction correlates with the overall surgical population.
PubMed 文献 · J Plast Reconstr Aesthet Surg · 2018-06-08

本研究为单中心回顾性队列研究,回顾2011至2016年接受下肢游离皮瓣手术的100例患者病历,发现3例肝素诱导性血小板减少症(HIT),其中1例因既往HIT诊断被排除。下肢游离皮瓣患者HIT发生率介于1%至3%,与全国平均水平一致;4T与HEP评分有助于在缺乏快速免疫学确认试验时评估围手术期HIT风险。

要点

  • 下肢游离皮瓣患者HIT发生率约1%–3%,与全国平均水平一致。
  • 4T评分中2/3的HIT阳性患者为高概率(约64%),1/3为中概率(约14%)。
  • HEP评分判定全部3例(100%)HIT阳性患者为HIT。

核心结论

  • 下肢游离皮瓣重建患者的HIT发生率与全国HIT发生率相关。
  • 可用评分方法结合病史有助于在无快速免疫学确认试验时评估围手术期HIT风险。
  • 该认识可支持游离皮瓣挽救成功或对有HIT病史患者实施游离皮瓣。

研究设计与样本

  • 回顾性、单中心、经IRB批准的队列研究。
  • 回顾2011年至2016年接受下肢游离皮瓣手术的全部患者病历。
  • 共复习100份患者病历,计算4T评分与HIT Expert Probability(HEP)评分评估HIT可能性。

主要发现

  • 100例患者中发现3例HIT,其中1例因既往HIT诊断被排除。
  • 接受下肢游离皮瓣患者的HIT发生率介于1%至3%,与全国平均水平一致。
  • 4T评分显示3例HIT阳性患者中2例为高概率(约64%),1例为中概率(约14%)。
  • HEP评分显示全部3例(100%)HIT阳性患者为HIT。

关键数值与推荐

  • HIT发生率范围为1%至3%,与全国平均水平一致。
  • 4T评分高概率约64%,中概率约14%。
  • HEP评分阳性率为100%(3例中3例)。

临床怎么用

  • 对下肢游离皮瓣患者可用4T与HEP评分结合病史评估围手术期HIT风险。
  • 在缺乏快速免疫学确认试验时,评分结果可辅助决策以争取皮瓣挽救或对有HIT病史者实施游离皮瓣。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Lower-extremity free flap reconstruction is a growing trend in the management of lower extremity wounds. Heparin-induced thrombocytopenia (HIT) is a significant risk to free flap reconstruction. The purpose of this study was to investigate the incidence of HIT in patients receiving lower-extremity free flap surgery. METHODS: We conducted a retrospective, single center, IRB approved cohort study in which we reviewed all patients who received lower-extremity free flap surgeries between 2011 and 2016. The 4T and HIT Expert Probability (HEP) scores were calculated to assess the likelihood of HIT. RESULTS: One hundred patient charts revealed three patients with HIT. One patient was excluded due to a prior diagnosis of HIT. HIT incidence in patients receiving lower-extremity free flaps was between 1% and 3%, which is consistent with the national average. 4T scores indicated that two of three HIT-positive patients had a high probability of HIT (approximately 64%), and one of three HIT-positive patients had an intermediate probability (approximately 14%). HEP scoring indicated that all the three (100%) patients had HIT. CONCLUSIONS: These data suggest that the incidence of HIT in patients receiving lower-extremity free flaps correlates with the incidence of HIT nationally. The use of available scoring methods and other algorithms, combined with patient history helps to assess the immediate perioperative risks of HIT in the absence of rapid immunologic confirmatory tests. This knowledge can allow for successful free flap salvage or for performance of free flaps in patients with a history of HIT.

来源:J Plast Reconstr Aesthet Surg,查看原文。版权归原作者所有。

引用

  1. Stimac G, Walters ET, Elmarsafi T, et al. Incidence of heparin-induced thrombocytopenia in lower-extremity free flap reconstruction correlates with the overall surgical population. J Plast Reconstr Aesthet Surg. 2018. PMID: 29980457. doi:10.1016/j.bjps.2018.05.034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。